跳至主要内容
临床试验/NCT05014945
NCT05014945已完成不适用

Effect of Combination Therapy With Atelocollagen in Epidural Nerve Block in Patients With Chronic Low Back Pain From Degenerative Lumbar Spine: Pilot Study

Gangnam Severance Hospital1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2021年8月16日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
1
主要终点
cross-sectional area of the multifidus muscle

研究概览

简要总结

"In this study, the investigators plan to evaluate muscle mass and pain relief 4 weeks after performing epidural nerve block and Type I porcine atelocollagen injection into multifidus muscle in patients with chronic low back pain due to degenerative spinal disease for more than 6 months.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients scheduled for epidural nerve block for lower back pain
  • •Patients over 21 years of age
  • •Back pain lasting more than 6 months
  • •Patients with ineffective or insignificant effects of conventional drugs and nerve block for back pain
  • •Patients with spinal stenosis or disc herniation at the lumbar 4-5 or lumbar 5-sacral 1 level on MRI, and the cross-sectional area of the multifidus muscle at the lesion site is less than 5 cm2 when measured by ultrasound.

排除标准

  • •When the degree of low back pain is 3 points or less on the 11-scale numeric rating scale (hereafter NRS)
  • •If lower back pain has rapidly worsened within the last week
  • •If you have other diseases that may cause low back pain: osteoarthritis of the hip joint, cancer, inflammatory arthritis, spondylitis, fibromyalgia, complex regional pain syndrome, herpes zoster, postherpetic neuralgia, etc.
  • •When a diagnostic epidural nerve block is planned
  • •In the case of receiving conservative treatment, procedure, or surgery other than oral drugs such as epidural nerve block or proliferation treatment for the treatment of lower back pain within 4 weeks of screening
  • •When the low back pain assessed by NRS decreased by more than 50% after epidural nerve block in screening
  • •If back surgery is planned within 3 months of the procedure
  • •When NRS and ODI measurements cannot be made
  • •When collagen injection is contraindicated (eg when allergic to swine)
  • •Pregnant women
  • •If you cannot read or agree to the consent form
  • •If you are unable to sign the consent form yourself

研究组 & 干预措施

Atelocollagen group

Experimental

After obtaining informed consent for the study, epidural nerve block was performed. The patient is asked to return to the outpatient clinic of the pain center after 2 weeks. At this time, when the NRS of back pain does not improve by more than 50% compared to before the epidural nerve block and the cross-sectional area of the multifidus muscle using ultrasound is 5 cm2 or less, final enrollment is decided. The evaluation of the cross-sectional area and thickness of the multifidus muscle using ultrasound is performed with the patient prone, and the cross-sectional area of the multifidus muscle is measured at the same position as the level of the lesion on MRI.

干预措施: (atelocollagen group) (Procedure)

结局指标

主要结局

cross-sectional area of the multifidus muscle

时间窗: 28 days after atelocollagen injection

Changes in the cross-sectional area of the multifidus muscle at the 4th week of the intervention compared to before the intervention (measured value using ultrasound at outpatient).

次要结局

  • numeric rating score(28 days after atelocollagen injection)
  • oswestry disability index(28 days after atelocollagen injection)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ji Yeong Kim

Associate Professor

Gangnam Severance Hospital

研究点 (1)

Loading locations...

相似试验